Discover Orange Biomed’s revolutionary new A1c testing method, set to debut at ADA 2024. Get a preview before its public release and transform diabetes care.
Orange Biomed joins MEDICA Diabetes Technology Meeting to highlight A1c testing gaps and raise awareness for innovative solutions in diabetes care.
ADA 2023 Recap: Discover Orange Biomed’s groundbreaking A1c testing method for improved diabetes management, diagnosis, and other key conference highlights.
Explore how health inequities impact communities of color and why education and early testing for conditions like diabetes can be life-saving measures.
To improve diabetes management and patient outcomes, in 2018, NYU began offering patients A1c blood testing during emergency room visits to determine if they had diabetes.
Diabetes care for patients accounts for 1 in 4 healthcare dollars spent in the U.S. A large part of these costs is spent on diabetes-associated comorbidities.
A1c tests are more likely to produce inaccurate results for Black patients. Why? Because hemoglobin variants are more common in people with African, South and Southeast Asian, and Mediterranean ancestry.
Discover how immediate POC A1c test results can boost critical diabetes interventions by over 50%, revolutionizing care and improving patient outcomes.
